Oda Y, Kumagai Y, Kanai M, Iwama Y, et al. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet Infect Dis 2023 Dec 20:S1473-3099(23)00650.
PMID: 38141632